Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer-Reference-Cited by-同舟云学术

Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer

Published:2019-04-08 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Xiao Yangjiong,Yu Yang,Gao Dan,Jin Wangrui,Jiang Pengcheng,Li Yuhong,Wang Chao,Song Yuning,Zhan Peng,Gu Fei,Zhang Cancan,Wang Bin,Chen Yihua,Du Bing,Zhang Rong

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference42 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin.,2018

2. Rethinking ovarian cancer: recommendations for improving outcomes;Vaughan;Nat Rev Cancer.,2011

3. Global cancer statistics, 2012;Torre;CA Cancer J Clin.,2015

4. Targeted therapies for ovarian cancer;Grunewald;Best Pract Res Clin Obstet Gynaecol.,2017

5. Parp inhibitors for the treatment of ovarian cancer;Cortesi;Curr Cancer Drug Targets,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest;Bioorganic Chemistry;2024-11

2. Natural product cell division cycle 25 (CDC25) inhibitors: A promising source for cancer drug discovery;Journal of the Indian Chemical Society;2024-08

3. Upregulation of CDC25B by transcription factor TEAD4 drives invasion and inhibits cisplatin sensitivity through cell adhesion in stomach adenocarcinoma;Anti-Cancer Drugs;2024-07-23

4. E2F1 Facilitates the Proliferation and Stemness of Gastric Cancer Cells by Activating CDC25B Transcription and Modulating the MAPK Pathway;Biochemical Genetics;2024-07-09

5. Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine;Frontiers in Pharmacology;2024-01-19